250
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

An instrument for assessing progress in substance use disorder treatment: a pilot study of initial reliability and factor structure of the Treatment Progress Assessment-8

, , , &

References

  • Office of Surgeon General. Facing addiction in America: the surgeon general’s report on alcohol, drugs, and health. Washington (DC): US Department of Health and Human Services; 2016.
  • Padwa H, Urada D, Gauthier P, Rieckmann T, Hurley B, Crèvecouer-MacPhail D, Rawson RA. Organizing publicly funded substance use disorder treatment in the United States: moving toward a service system approach. J Subst Abuse Treat. 2016;69:9–18. doi:10.1016/j.jsat.2016.06.010.
  • Substance Abuse and Mental Health Services Administration. Treatment episode data set (TEDS): 2005–2015. State admissions to substance abuse treatment services. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2017.
  • Institute of Medicine (US) Committee on Crossing the Quality Chasm: Adaptation to Mental Health and Addictive Disorders. Improving the quality of health care for mental and substance-use conditions. National Academy Press, Washington DC; 2006.
  • Hunter SB, Ober AJ, Paddock SM, Hunt PE, Levan D. Continuous quality improvement (CQI) in addiction treatment settings: design and intervention protocol of a group randomized pilot study. Addict Sci Clin Pract. 2014;9:1–11. doi:10.1186/1940-0640-9-4.
  • Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med. 2007;22:1596–602. doi:10.1007/s11606-007-0333-y.
  • Reilly S, Planner C, Gask L, Hann M, Knowles S, Druss B, Lester H. Collaborative care approaches for people with severe mental illness. Cochrane Libr. (11) Art. No.: CD009531; 2013. doi:10.1002/14651858.CD009531.pub2.
  • Ling W, Farabee D, Liepa D, Wu L-T. The Treatment effectiveness assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addiction. Subst Abuse Rehabil. 2012;3:129–36.
  • National Council for Behavioral Health. Implementing Care for Alcohol & Other Drug Use in Medical Settings: An Extension of SBIRT. 2018.
  • Street RL, Jr Gold WR, McDowell T. Using health status surveys in medical consultations. Med Care. 1994;32:732–44. doi:10.1097/00005650-199407000-00006.
  • American Psychiatric Assocation. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub., Arlington, VA; 2013.
  • Cottler LB, Schuckit MA, Helzer JE, Crowley T, Woody G, Nathan P, Hughes J. The DSM-IV field trial for substance use disorders: major results. Drug Alcohol Depend. 1995;38:59–69. doi:10.1016/0376-8716(94)01091-X.
  • Brownell KD, Marlatt GA, Lichtenstein E, Wilson GT. Understanding and preventing relapse. Am Psychol. 1986;41:765–82. doi:10.1037/0003-066X.41.7.765.
  • Daley DC. Family and social aspects of substance use disorders and treatment. J Food Drug Anal. 2013;21:S73–S76. doi:10.1016/j.jfda.2013.09.038.
  • Rodriguez LM, Derrick J. Breakthroughs in understanding addiction and close relationships. Curr Opin Psychol. 2017;13:115–19. doi:10.1016/j.copsyc.2016.05.011.
  • Sayette MA. The role of craving in substance use disorders: theoretical and methodological issues. Annu Rev Clin Psychol. 2016;12:407–33. doi:10.1146/annurev-clinpsy-021815-093351.
  • Lyvers M. Loss of control” in alcoholism and drug addiction: a neuroscientific interpretation. Exp Clin Psychopharmacol. 2000;8:225–49. doi:10.1037/1064-1297.8.2.225.
  • Ilgen M, McKellar J, Tiet Q. Abstinence self-efficacy and abstinence 1 year after substance use disorder treatment. J Consult Clin Psychol. 2005;73(6):1175–180. doi:10.1037/0022-006X.73.6.1175.
  • Kadden RM, Litt MD. The role of self-efficacy in the treatment of substance use disorders. Addict Behav. 2011;36:1120–126. doi:10.1016/j.addbeh.2011.07.032.
  • Chavarria J, Stevens EB, Jason LA, Ferrari JR. The effects of self-regulation and self-efficacy on substance use abstinence. Alcohol Treat Q. 2012;30:422–32. doi:10.1080/07347324.2012.718960.
  • Ilgen MA, McKellar J, Moos R, Finney JW. Therapeutic alliance and the relationship between motivation and treatment outcomes in patients with alcohol use disorder. J Subst Abuse Treat. 2006;31:157–62. doi:10.1016/j.jsat.2006.04.001.
  • Connors GJ, Carroll KM, DiClemente CC, Longabaugh R, Donovan DM. The therapeutic alliance and its relationship to alcoholism treatment participation and outcome. J Consult Clin Psychol. 1997;65:588. doi:10.1037/0022-006X.65.4.588.
  • Meier PS, Barrowclough C, Donmall MC. The role of the therapeutic alliance in the treatment of substance misuse: a critical review of the literature. Addiction. 2005;100:304–16. doi:10.1111/j.1360-0443.2004.00935.x.
  • Berking M, Margraf M, Ebert D, Wupperman P, Hofmann SG, Junghanns K. Deficits in emotion-regulation skills predict alcohol use during and after cognitive–behavioral therapy for alcohol dependence. J Consult Clin Psychol. 2011;79:307–18. doi:10.1037/a0023421.
  • Connors GJ, Maisto SA, Zywiak W. Male and female alcoholics' attributions regarding the onset and termination of relapses and the maintenance of abstinence. J Subst Abuse. 1998;10(1):27–42. doi:10.1016/S0899-3289(99)80138-2.
  • Wilcox CE, Pommy JM, Adinoff B. Neural circuitry of impaired emotion regulation in substance use disorders. Am J Psychiatry. 2016;173(4):344–61. doi:10.1176/appi.ajp.2015.15060710.
  • Krentzman AR. Review of the application of positive psychology to substance use, addiction, and recovery research. Psychol Addict Behav. 2013;27:151–65. doi:10.1037/a0029897.
  • Akhtar M, Boniwell I. Applying positive psychology to alcohol-misusing adolescents: a group intervention. Groupwork. 2010;20:6–31. doi:10.1921/095182410X576831.
  • Petit G, Luminet O, Maurage F, Tecco J, Lechantre S, Ferauge M, Gross JJ, de Timary P. Emotion regulation in alcohol dependence. Alcohol Clin Exp Res. 2015;39:2471–79. doi:10.1111/acer.12914.
  • Jakubczyk A, Trucco EM, Kopera M, Kobyliński P, Suszek H, Fudalej S, Brower KJ, Wojnar M. The association between impulsivity, emotion regulation, and symptoms of alcohol use disorder. J Subst Abuse Treat. 2018;91:49–56. doi:10.1016/j.jsat.2018.05.004.
  • Kopera M, Jakubczyk A, Suszek H, Glass JM, Klimkiewicz A, Wnorowska A, Brower KJ, Wojnar M. Relationship between emotional processing, drinking severity and relapse in adults treated for alcohol dependence in Poland. Alcohol Alcohol. 2015;50:173–79. doi:10.1093/alcalc/agu099.
  • Krentzman AR, Barker SL. Counselors' perspectives of positive psychology for the treatment of addiction: a mixed methods pilot study. Alcohol Treat Q. 2016;34:370–85. doi:10.1080/07347324.2016.1217705.
  • Katz EC, King SD, Schwartz RP, Weintraub E, Barksdale W, Robinson R, Brown BS. Cognitive ability as a factor in engagement in drug abuse treatment. Am J Drug Alcohol Abuse. 2005;31:359–69. doi:10.1081/ADA-200056767.
  • Mathis GM, Ferrari JR, Groh DR, Jason LA. Hope and substance abuse recovery: the impact of agency and pathways within an abstinent communal-living setting. J Groups Addict Recover. 2009;4:42–50. doi:10.1080/15560350802712389.
  • Irving LM, Seidner AL, Burling TA, Pagliarini R, Robbins-Sisco D. Hope and recovery from substance dependence in homeless veterans. J Social Clin Psychol. 1998;17:389–406. doi:10.1521/jscp.1998.17.4.389.
  • Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, Lincoln M, Hien D, Miele GM. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86:1–21. doi:10.1016/j.drugalcdep.2006.05.012.
  • McHugh RK, DeVito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, Connery HS, Weiss RD. Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat. 2013;45:38–43. doi:10.1016/j.jsat.2012.12.007.
  • Blanco C, Iza M, Rodríguez-Fernández JM, Baca-García E, Wang S, Olfson M. Probability and predictors of treatment-seeking for substance use disorders in the U.S. Drug Alcohol Depend. 2015;149:136–44. doi:10.1016/j.drugalcdep.2015.01.031.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.